Crude Oil Rises Over 1%; Cidara Therapeutics Shares Spike Higher
Portfolio Pulse from Lisa Levin
U.S. stocks traded lower with the Nasdaq Composite falling more than 1%. Core & Main Inc reported a Q2 miss and narrowed its FY23 guidance. Palisade Bio, Cidara Therapeutics, and Marin Software saw their shares rise due to various positive developments. EZGO Technologies, Akoustis Technologies, and AMC Entertainment saw their shares drop due to negative news. Crude oil rose by 1.4% while gold and silver traded down.
September 06, 2023 | 6:41 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Akoustis Technologies' shares were down after the company reported Q4 FY23 revenue growth that missed the consensus, which could negatively impact its stock price.
Akoustis Technologies' Q4 FY23 revenue growth missing the consensus indicates potential financial instability, which could lead to a decrease in investor confidence and a drop in the stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80
NEGATIVE IMPACT
AMC Entertainment's shares fell after the company entered an equity distribution agreement for up to 40 million shares, which could negatively impact its stock price.
The equity distribution agreement for up to 40 million shares could dilute existing shareholders' equity, which could lead to a decrease in investor confidence and a drop in the stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80
NEGATIVE IMPACT
Core & Main Inc reported a Q2 miss and narrowed its FY23 guidance, which could negatively impact its stock price.
Core & Main's Q2 miss and narrowed FY23 guidance indicate potential financial instability, which could lead to a decrease in investor confidence and a drop in the stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80
NEGATIVE IMPACT
EZGO Technologies' shares dropped after the company reported pricing of $10 million registered direct offering, which could negatively impact its stock price.
The pricing of the $10 million registered direct offering could dilute existing shareholders' equity, which could lead to a decrease in investor confidence and a drop in the stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Cidara Therapeutics' shares got a boost after Janssen elected to proceed under its license agreement, which could positively impact its stock price.
Janssen's decision to proceed under its license agreement with Cidara Therapeutics could lead to new revenue streams for the company, which could increase investor confidence and drive the stock price up.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Marin Software's shares rose after the company reported HubSpot integration, which could positively impact its stock price.
The HubSpot integration could lead to new business opportunities for Marin Software, which could increase investor confidence and drive the stock price up.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Palisade Bio's shares shot up due to an exclusive worldwide licensing agreement with Giiant Pharma, which could positively impact its stock price.
The exclusive worldwide licensing agreement with Giiant Pharma could lead to new revenue streams for Palisade Bio, which could increase investor confidence and drive the stock price up.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80